These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7678425)

  • 1. Effects of nutrient intake on growth, insulin-like growth factors, and their binding proteins in a Laron-type dwarf.
    Crosnier H; Gourmelen M; Prévot C; Rappaport R
    J Clin Endocrinol Metab; 1993 Jan; 76(1):248-50. PubMed ID: 7678425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.
    van Buul-Offers SC; Reijnen-Gresnigt MG; Hoogerbrugge CM; Bloemen RJ; Kuper CF; Van den Brande JL
    Endocrinology; 1994 Sep; 135(3):977-85. PubMed ID: 7520865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
    Vasilatos-Younken R; Dunnington EA; Siegel PB; McMurtry JP
    Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.
    Kanety H; Karasik A; Klinger B; Silbergeld A; Laron Z
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):144-9. PubMed ID: 7680834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
    Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
    Laron Z; Klinger B; Blum WF; Silbergeld A; Ranke MB
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy flux, more so than energy balance, protein intake, or fitness level, influences insulin-like growth factor-I system responses during 7 days of increased physical activity.
    Rarick KR; Pikosky MA; Grediagin A; Smith TJ; Glickman EL; Alemany JA; Staab JS; Young AJ; Nindl BC
    J Appl Physiol (1985); 2007 Nov; 103(5):1613-21. PubMed ID: 17702838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-binding proteins and insulin-like growth factor-binding proteins in protein-energy malnutrition, before and after nutritional rehabilitation.
    Zamboni G; Dufillot D; Antoniazzi F; Valentini R; Gendrel D; Tato L
    Pediatr Res; 1996 Mar; 39(3):410-4. PubMed ID: 8929859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.
    Azziz R; Deal CL; Potter HD; Gargosky SE; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1747-51. PubMed ID: 7527410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
    Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
    J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
    Camacho-Hubner C; Clemmons DR; D'Ercole AJ
    Endocrinology; 1991 Sep; 129(3):1201-6. PubMed ID: 1714829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.